Cite
HARVARD Citation
Cui, J. et al. (2020). Oral versus intravenous palonosetron in Chinese cancer patients receiving moderately emetogenic chemotherapy: A non‐inferiority phase III trial. European journal of cancer care. p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cui, J. et al. (2020). Oral versus intravenous palonosetron in Chinese cancer patients receiving moderately emetogenic chemotherapy: A non‐inferiority phase III trial. European journal of cancer care. p. n/a. [Online].